Behind the Paper: How PRICKLE3 Found Its Place in WNT/PCP Signalling

Behind every research paper, there is a long story that is usually invisible to the reader. Our paper is no exception. What began as a focused cell biology project gradually developed into a broad, collaborative effort across laboratories, model systems, and countries.

Published in Biomedical Research

Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Starting with cells and a simple question

The project started in our lab at Masaryk University in Brno with a basic but persistent question: what is the specific role of PRICKLE3 in the WNT/planar cell polarity (PCP) pathway?

While PRICKLE1 and PRICKLE2 have been studied extensively, PRICKLE3 was often considered less important or poorly defined. We were not fully convinced by this view, and early experiments in human cell lines already suggested that PRICKLE3 behaves differently from the other family members.

At this early stage, much of the experimental work was driven by Katarzyna (Kasia) Radaszkiewicz, whose careful and systematic approach helped shape the direction of the project.

A turning point: proteomics

A major shift came when we decided to use proximity-dependent biotinylation (miniTurboID) combined with mass spectrometry. This allowed us to move beyond candidate interactions and map PRICKLE protein environments in an unbiased way.

With strong support from the CEITEC proteomics core facility and close collaboration with bioinformatic experts, we generated comparative interactomes of PRICKLE1, PRICKLE2, and PRICKLE3. The result was striking: PRICKLE3 displayed a clearly distinct interaction network, strongly enriched in core non-canonical WNT/PCP components, including VANGL1 and VANGL2.

This finding changed the scope of the project. What started as a cell biology study became a mechanistic investigation of PCP receptor regulation.

From interactions to mechanism

We then focused on understanding what PRICKLE3 actually does. Using inducible cell lines, biochemical assays, and imaging, we found that PRICKLE3 stabilizes VANGL proteins at the plasma membrane.

Mechanistically, PRICKLE3 reduces CK1ε-mediated phosphorylation of VANGL and protects it from RNF43-dependent ubiquitination and degradation. Importantly, this function was specific to PRICKLE3 and was not observed for PRICKLE1, highlighting functional specialization within the PRICKLE family.

Many of these experiments were technically demanding and required careful optimization and repetition. Progress was steady, but not always fast — a familiar situation in long-term projects.

Extending the work in vivo

To test whether these mechanisms are relevant beyond cell culture, we expanded the study to vertebrate embryos. Xenopus allowed us to validate VANGL stabilization in vivo, while zebrafish embryos enabled direct visualization of PCP-related membrane dynamics during development.

At this stage, international collaboration became essential. Colleagues in Singapore contributed expertise in zebrafish biology and advanced imaging, adding an important in vivo dimension to the work and strengthening the overall conclusions.

A long but rewarding process

This project developed over several years, during which the team evolved and new challenges appeared. Bringing all experimental, proteomic, and in vivo data together into a coherent story required persistence, coordination, and a strong collaborative spirit.

Why it matters

Beyond identifying a new role for PRICKLE3, this work reveals a previously unrecognized regulatory layer controlling the stability of PCP receptor complexes. By linking PRICKLE3 to CK1ε and RNF43, we provide new insight into how non-canonical WNT signalling is fine-tuned during development and disease.

We also hope that the datasets and molecular tools generated in this study will be useful for the wider community.

Final thoughts

Behind this paper is a story of curiosity, teamwork, and long-term commitment. It also shows that proteins considered “minor” can play central roles when studied with the right tools and sufficient patience.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biomedical Research
Life Sciences > Health Sciences > Biomedical Research

Related Collections

With Collections, you can get published faster and increase your visibility.

Women's Health

A selection of recent articles that highlight issues relevant to the treatment of neurological and psychiatric disorders in women.

Publishing Model: Hybrid

Deadline: Ongoing

Advances in neurodegenerative diseases

This Collection aims to bring together research from various domains related to neurodegenerative conditions, encompassing novel insights into disease pathophysiology, diagnostics, therapeutic developments, and care strategies. We welcome the submission of all papers relevant to advances in neurodegenerative disease.

Publishing Model: Hybrid

Deadline: Mar 24, 2026